Crisugabalin
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Crisugabalin
- DrugBank Accession Number
- DB19300
- Background
Crisugabalin is under investigation in clinical trial NCT06490484 (Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 209.289
Monoisotopic: 209.141578856 - Chemical Formula
- C12H19NO2
- Synonyms
- Crisugabalin
- External IDs
- HSK 16149
- HSK-16149
- HSK16149
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Q3MK7E8686
- CAS number
- 2209104-84-5
- InChI Key
- WCEFMBSFXJUREW-LIJGXYGRSA-N
- InChI
- InChI=1S/C12H19NO2/c13-6-12(5-11(14)15)9-2-1-7-3-8(9)10(12)4-7/h7-10H,1-6,13H2,(H,14,15)/t7-,8-,9-,10+,12+/m0/s1
- IUPAC Name
- SMILES
- [H][C@@]12C[C@H]3C[C@]1([H])[C@](CN)(CC(O)=O)[C@]2([H])CC3
References
- General References
- Not Available
- External Links
- ChemSpider
- 115009778
- Wikipedia
- Crisugabalin
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data3 Active Not Recruiting Treatment Peripheral Neuropathic Pain 1 somestatus stop reason just information to hide 3 Completed Treatment Postherpetic Neuralgia 1 somestatus stop reason just information to hide 3 Not Yet Recruiting Treatment Central Neuropathic Pain 1 somestatus stop reason just information to hide 2 Completed Treatment Herpetic Neuralgia 1 somestatus stop reason just information to hide 2 Completed Treatment Postoperative pain 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at July 21, 2024 05:35 / Updated at July 21, 2024 07:38